


The Fund aims to achieve a long-term return, in excess of the long-term return that is typically achieved from United Kingdom equity markets.
| Name | % Net Assets | 
|---|---|
| GlaxoSmithKline | 7.1% | 
| ASTRAZENECA PLC | 5.4% | 
| BP | 5.2% | 
| ROYAL DUTCH SHELL | 4.3% | 
| Vodafone | 3.9% | 
| HSBC HLDGS | 3.7% | 
| Unilever | 3.7% | 
| Centrica | 3.6% | 
| RSA INSURANCE GROUP PLC | 3.5% | 
| NATIONAL GRID | 3.4% | 
| Key | % Net Assets | 
|---|---|
| 7.1% | |
| 5.4% | |
| 5.2% | |
| 4.3% | |
| 78% | 
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | 01/02/1972 | 
|---|---|
| Fund Manager | Chris Burvill | 
| TER | 1.66 (30-Nov-2010) | 
| Minimum Investment | |
|---|---|
| Initial | 1000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.11 | 
You are here: research